Unique ID issued by UMIN | UMIN000005850 |
---|---|
Receipt number | R000006912 |
Scientific Title | Molecular imaging of DNA synthesis: Diagnosis of cancer using a new PET tracer |
Date of disclosure of the study information | 2011/07/01 |
Last modified on | 2019/03/18 19:22:05 |
Molecular imaging of DNA synthesis: Diagnosis of cancer using a new PET tracer
4'-[methyl-11C]thiotymidine(4DST)PET for cancer diagnosis
Molecular imaging of DNA synthesis: Diagnosis of cancer using a new PET tracer
4'-[methyl-11C]thiotymidine(4DST)PET for cancer diagnosis
Japan |
Lung cancer
Multiple myeloma
Esophageal cancer
Head and neck caner
Gastroenterology | Cardiology | Pneumology |
Hematology and clinical oncology | Gastrointestinal surgery | Chest surgery |
Oto-rhino-laryngology | Radiology | Cardiovascular surgery |
Malignancy
NO
To evaluate the utility of 4DST-PET for diagnosis and therapy evaluation of cancer.
Efficacy
Exploratory
Phase II
As a surrogate marker of tumor proliferation and of therapeutic response, 4DST-PET could be superior than FDG-PET.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Diagnosis
Other |
4DSTPET and FDGPET in a same patient will be compared to the pathology or to the clinical golden standards.
20 | years-old | <= |
Not applicable |
Male and Female
1. Patient who is pathologically diagnosed as malignancy.
2.Age: >20 years.
3. Capability to have PET scan.
4. Completed the written informed consent
1. Unable to have signed informed consent.
2.Patient with severe underlying disease having risk of liver dysfunction, renal dysfunction and any metabolic damage.
3. Just after surgery and/or trauma
4. Uncontrollable diabetics
5. Those who are determined as not appropriate for the study by physician in chief.
300
1st name | |
Middle name | |
Last name | Ryogo Minamimoto |
National Center for Global Health and Medicine
Department of Radiology, Division of Nuclear Medicine
1-21-1, Toyama, Shinjyuku-ku, Tokyo
03-3202-7181
rminamimoto@hosp.ncgm.go.jp
1st name | |
Middle name | |
Last name | Ryogo Minamimoto |
National Center for Global Health and Medicine
Department of Radiology, Division of Nuclear Medicine
1-21-1, Toyama, Shinjyuku-ku, Tokyo
03-3202-7181
rikensa@lily.ocn.ne.jp
National Center for Global Health and Medicine
National Center for Global Health and Medicine
Other
Japan
Tokyo Metropolitan Institute for Gerontology
NO
国立国際医療研究センター病院(東京都)
2011 | Year | 07 | Month | 01 | Day |
Partially published
We compared the maximum standardized uptake value (SUVmax) of lung tumors on both 11C-4DST and 18F-FDG PET/CT with the Ki-67 index of cellular proliferation and with CD31-positive vessels as a marker of angiogenesis in surgical pathology. The correlation coefficient between SUVmax and Ki-67 index was higher with 11C-4DST (r = 0.82) than with 18F-FDG (r = 0.71). That with CD31 was low for both tracers. 11C-4DST PET/CT may allow noninvasive imaging of DNA synthesis in NSCLC.
Minamimoto R, st al. J Nucl Med 2012;53:199-206.
Completed
2011 | Year | 06 | Month | 01 | Day |
2010 | Year | 06 | Month | 25 | Day |
2010 | Year | 07 | Month | 01 | Day |
2019 | Year | 03 | Month | 31 | Day |
FDG uptake by tumor tissue, 4DST uptake by tumor tissue, MIB-1 index by immuno-staining of Ki-67 of resected tumor tissue, histopathological type, these informations will be compared.
2011 | Year | 06 | Month | 26 | Day |
2019 | Year | 03 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006912
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |